Clinical Trials Directory

Trials / Conditions / Red-Cell Aplasia, Pure

Red-Cell Aplasia, Pure

6 registered clinical trials studyying Red-Cell Aplasia, Pure.

StatusTrialSponsorPhase
UnknownPure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa
NCT02648126
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)Phase 4
UnknownIdentifying Characteristics of Bone Marrow Failure Syndromes
NCT00315419
Office of Rare Diseases (ORD)—
CompletedRituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
NCT00229619
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
CompletedStudy to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Parti
NCT00210951
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.—
CompletedA Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) Whil
NCT00211029
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.—
CompletedStudy of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant He
NCT00005893
Fairview University Medical CenterN/A